Patents Represented by Attorney Laureles A. Duncan

Find this attorney in the Justia Lawyer Directory

  • Heterocyclic containing biphenyl aP2 inhibitors and method
    Patent number: 6927227
    Abstract: aP2 inhibiting compounds are provided having the formula wherein R1, R2, R3, R4, X—Z and are as described herein. A method is also provided for treating diabetes and related diseases, especially Type II diabetes, employing such aP2 inhibitor or a combination of such aP2 inhibitor and another antidiabetic agent such as metformin, glyburide, troglitazone and/or insulin.
    Type: Grant
    Filed: December 17, 2002
    Date of Patent: August 9, 2005
    Assignee: Bristol-Myers Squibb Company
    Inventors: Jeffrey A. Robl, David R. Magnin